EE105 Cost-Effectiveness Analysis of Linperlisib for Relapsed or Refractory Follicular Lymphoma Based on Matching Adjusted Indirect Comparison in China

Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.404
https://www.valueinhealthjournal.com/article/S1098-3015(24)00519-9/fulltext
Title : EE105 Cost-Effectiveness Analysis of Linperlisib for Relapsed or Refractory Follicular Lymphoma Based on Matching Adjusted Indirect Comparison in China
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00519-9&doi=10.1016/j.jval.2024.03.404
First page :
Section Title :
Open access? : No
Section Order : 11753
Categories :
Tags :
Regions :
ViH Article Tags :